Technology, Science, & Me!: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology, Science, & Me!.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on March 28, 2026

Mar. 28, 2026

Spotlight On Startups Releases New Guide to Help Orange County Businesses Get Cited by ChatGPT

EIN Presswire

Mar. 28, 2026

Aftab Uddin Presents Next-Generation AI Risk Model for U.S. Financial Stability and Portfolio Optimization

EIN Presswire

Mar. 28, 2026

ProHance Showcases Measurable Productivity Impact at SSOW 2026, Shifting from Transformation to Tangible Outcomes

EIN Presswire

Mar. 28, 2026

The Future of Automated Coffee: Anno Robot’s 6-Axis AI Solutions vs. Traditional Vending

EIN Presswire

Mar. 28, 2026

Automation Guide: Selecting a China Intelligent Plastic Blowing Machine Manufacturer and Why Pio-Engineer Stands Out

EIN Presswire

Mar. 28, 2026

One-Stop China Electrical Supplier — YOTI Factory for GFCI, Sensor Switch, USB Outlet & PD Charger

EIN Presswire

Mar. 28, 2026

MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting

GlobeNewswire

Mar. 28, 2026

Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity

GlobeNewswire

Mar. 28, 2026

New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis

GlobeNewswire

Mar. 28, 2026

Alumis’ Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Trials, Underscoring Its Potential as a Leading Oral Therapy for Plaque Psoriasis

GlobeNewswire

Mar. 28, 2026

Communiqué de presse : AAD : Sanofi présente de nouveaux résultats de phase 3 pour l'amlitelimab dans la dermatite atopique lors d'une session de dernière minute

GlobeNewswire

Mar. 28, 2026

Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting

GlobeNewswire

Mar. 28, 2026

Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session

GlobeNewswire

Mar. 28, 2026

Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting

GlobeNewswire

Mar. 28, 2026

CODE27 Secures Over $10 Million in Funding to Build Immersive Interactive Character Companion Hardware

GlobeNewswire

Mar. 28, 2026

New Trailer and Iconic Key Visual Unveiled for THE GHOST IN THE SHELL at AnimeJapan 2026

EIN Presswire

Mar. 28, 2026

Rocket Lab Successfully Launches 85th Mission and First Dedicated Launch for European Space Agency

GlobeNewswire

Mar. 28, 2026

DeerValley Redefines Bathroom Hygiene with Launch of Premium V3 Smart Toilet Series

GlobeNewswire

Mar. 28, 2026

Cointelegraph Research covers UNDP's new blockchain report on modernizing public infrastructure

GlobeNewswire

Mar. 28, 2026

LegacyCoin CTO Announces Launch of Crypto Ownership Solution Focused on Digital Asset Continuity

GlobeNewswire